Paper42226197
Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer.
Zhao Y and 13 others. J Nanobiotechnology, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer. Papers, record 42226197. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42226197
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Supramolecular coordination nanoplatform amplifies oxidative stress to overcome ferroptosis resistance in gallbladder cancer.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ferroptosis | Major topic |
| Oxidative Stress | Major topic |
| Gallbladder Neoplasms | Major topic |
| Humans | |
| Animals | |
| Cell Line, Tumor | |
| Mice | |
| Reactive Oxygen Species | |
| Tumor Microenvironment | |
| Porphyrins | |
| Chlorophyllides | |
| Female | |
| Antioxidants | |
| Antineoplastic Agents | |
| Iron |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 82504141 | the National Natural Science Foundation of China | PubMed | ||
| No. 32130036 | the National Natural Science Foundation of China | PubMed | ||
| 10000015Z155080000004 | the National Clinical Key Specialty Construction Project | PubMed | ||
| No. Qiankeherencai XKBF [2025]025 | Guizhou Provincial Science and Technology Projects | PubMed |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25602130 | Nanoparticles in photodynamic therapy. | Chem Rev | 2015 | https://conductscience.org/library/papers/25602130 | PubMed |
| 2 | 38551494 | Diselenide-Containing Polymer Based on New Antitumor Mechanism as Efficient GSH Depletion Agent for Ferroptosis Therapy. | Adv Healthc Mater | 2024 | https://conductscience.org/library/papers/38551494 | PubMed |
| 3 | 37488674 | Isoliquiritigenin induces HMOX1 and GPX4-mediated ferroptosis in gallbladder cancer cells. | Chin Med J (Engl) | 2023 | https://conductscience.org/library/papers/37488674 | PubMed |
| 4 | 32985258 | The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK/mTOR mediated glycolysis in colorectal cancer. | Artif Cells Nanomed Biotechnol | 2020 | https://conductscience.org/library/papers/32985258 | PubMed |
| 5 | 31484489 | Contemporary perspectives on the use of radiation therapy for locally advanced gallbladder cancer. | Chin Clin Oncol | 2019 | https://conductscience.org/library/papers/31484489 | PubMed |
| 6 | 33846504 | Patient-derived organoids as a predictive biomarker for treatment response in cancer patients. | NPJ Precis Oncol | 2021 | https://conductscience.org/library/papers/33846504 | PubMed |
| 7 | 25237826 | Three-dimensional organotypic culture: experimental models of mammalian biology and disease. | Nat Rev Mol Cell Biol | 2014 | https://conductscience.org/library/papers/25237826 | PubMed |
| 8 | 36610291 | Overcoming cancer chemotherapy resistance by the induction of ferroptosis. | Drug Resist Updat | 2023 | https://conductscience.org/library/papers/36610291 | PubMed |
| 9 | 34580933 | Manipulating Intratumoral Fenton Chemistry for Enhanced Chemodynamic and Chemodynamic-Synergized Multimodal Therapy. | Adv Mater | 2021 | https://conductscience.org/library/papers/34580933 | PubMed |
| 10 | 22632970 | Ferroptosis: an iron-dependent form of nonapoptotic cell death. | Cell | 2012 | https://conductscience.org/library/papers/22632970 | PubMed |
| 11 | 40068597 | Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders. | Cancer Cell | 2025 | https://conductscience.org/library/papers/40068597 | PubMed |
| 12 | 31896010 | Isoliquiritigenin triggers developmental toxicity and oxidative stress-mediated apoptosis in zebrafish embryos/larvae via Nrf2-HO1/JNK-ERK/mitochondrion pathway. | Chemosphere | 2020 | https://conductscience.org/library/papers/31896010 | PubMed |
| 13 | 29274359 | Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. | Cancer Lett | 2018 | https://conductscience.org/library/papers/29274359 | PubMed |
| 14 | 32532289 | A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. | J Transl Med | 2020 | https://conductscience.org/library/papers/32532289 | PubMed |
| 15 | 39953537 | Eriodictyol-cisplatin coated nanomedicine synergistically promote osteosarcoma cells ferroptosis and chemosensitivity. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/39953537 | PubMed |
| 16 | 36372281 | Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. | Ann Oncol | 2023 | https://conductscience.org/library/papers/36372281 | PubMed |
| 17 | 30922733 | Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/30922733 | PubMed |
| 18 | 24439385 | Regulation of ferroptotic cancer cell death by GPX4. | Cell | 2014 | https://conductscience.org/library/papers/24439385 | PubMed |
| 19 | 37646139 | Advances in immunotherapy for biliary tract cancers. | Chin Med J (Engl) | 2024 | https://conductscience.org/library/papers/37646139 | PubMed |
| 20 | 23624327 | Preparation of isoliquiritigenin-loaded nanostructured lipid carrier and the in vivo evaluation in tumor-bearing mice. | Eur J Pharm Sci | 2013 | https://conductscience.org/library/papers/23624327 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GPX4 | 2879 | PubTator's text mining | https://conductscience.org/library/genes/2879 | NCBI Gene |
| HMOX1 | 3162 | PubTator's text mining | https://conductscience.org/library/genes/3162 | NCBI Gene |
| KEAP1 | 9817 | PubTator's text mining | https://conductscience.org/library/genes/9817 | NCBI Gene |
| NFE2L2 | 4780 | PubTator's text mining | https://conductscience.org/library/genes/4780 | NCBI Gene |
| NUP62 | 23636 | PubTator's text mining | https://conductscience.org/library/genes/23636 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42226197
GET https://conductscience.org/api/papers/v1/42226197/references?page=2